Opexa Therapeutics Poised For Breakout
Seeking Alpha
Merck KGaA signs $225 million personalized MS drug deal
Pharma Times, UK
Lessons From Biotech's Best Third Quarter Stocks
TheStreet.com
Biotechs Treating Incurable Disease Warrant Early Look
Seeking Alpha
Peregrine Shares SHOOT The Moon, Opexa’s New AGREEMENT
Wall Street Cheat Street
News
TheStreet.com

